Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.73
-1.01 (-14.99%)
At close: Feb 20, 2026, 4:00 PM EST
5.79
+0.06 (1.03%)
After-hours: Feb 20, 2026, 7:59 PM EST

Ardelyx Revenue

In the year 2025, Ardelyx had annual revenue of $407.32M with 22.09% growth. Ardelyx had revenue of $125.22M in the quarter ending December 31, 2025, with 7.82% growth.

Revenue (ttm)
$407.32M
Revenue Growth
+22.09%
P/S Ratio
3.45
Revenue / Employee
$1,031,190
Employees
395
Market Cap
1.41B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025407.32M73.71M22.09%
Dec 31, 2024333.62M209.16M168.06%
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 20182.61M-39.39M-93.79%
Dec 31, 201742.00M--
Dec 31, 2016---
Dec 31, 201524.03M-7.60M-24.02%
Dec 31, 201431.62M2.70M9.32%
Dec 31, 201328.93M23.52M434.71%
Dec 31, 20125.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Immatics99.45M
Intellia Therapeutics57.53M
uniQure15.75M
Zenas BioPharma15.00M
Capricor Therapeutics11.13M
AtaiBeckley3.02M
Revenue Rankings